Neuroprotezione del paziente con glaucoma cronico ad angolo aperto:ruolo della Citicolina in soluzione orale

Aim: To verify the efficacy of Citicoline, taken orally, in the prevention of neurological damage in patients with Chronic Open Angle Glaucoma (COA G). Methods: 30 subjects with COA G were divided into 2 groups: 18 subjects (CT group) were treated with Citicoline and 12 (PP group) were treated with placebo. Both groups underwent 3 cycles of treatment. A cycle lasted 60 days and after every cycle there was a wash-out period of 30 days. On day 0, 60, 90, 150, 180, 240 and 270 all subjects underwent an examination of the optic nerve fibres by GDx VVC and a simultaneous recording of pattern reversal VEP s and pattern ER G. Results: In both groups endocular pressure values kept steady below 21 m…